Protecting Kids from Pneumonia Annapolis MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Annapolis.

Perry S Shelton
(410) 224-3663
121 Old Solomons Island Rd
Annapolis, MD
Specialty
Pediatrics

Data Provided by:
Dr. Lani Smith Wheeler
(410) 573-1136
1 Harry S Truman Pkwy
Annapolis, MD
Specialty
Pediatrics

Annapolis Neurosurgery
(410) 266-2720
109 Defense Hwy
Annapolis, MD
 
Jay Thompson Rorick Jr, MD
(301) 281-6000
Annapolis, MD
Specialties
Pediatrics
Gender
Male
Education
Medical School: Or Hlth Sci Univ Sch Of Med, Portland Or 97201
Graduation Year: 1976

Data Provided by:
Lewis Christine P MD
(410) 224-4887
621 Ridgely Avenue
Annapolis, MD
 
Cardiology Associates
(301) 261-8531
2002 Medical Parkway
Annapolis, MD
 
Diego Anthony Escobosa
(410) 224-7667
2568a Riva Rd
Annapolis, MD
Specialty
Adolescent Medicine

Data Provided by:
Danneberger John E MD
(410) 266-8049
600 Ridgely Avenue Suite 130
Annapolis, MD
 
Robert William Moore, MD
(318) 675-5000
600 Ridgely Ave
Annapolis, MD
Specialties
Family Practice, Pediatrics
Gender
Male
Education
Medical School: Oh State Univ Coll Of Med, Columbus Oh 43210
Graduation Year: 1984

Data Provided by:
Jeffrey T Nold
(410) 224-7667
2568a Riva Rd
Annapolis, MD
Specialty
Adolescent Medicine

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com